US Patent 7446190 Nucleic acids encoding chimeric T cell receptors

US Patent 12129477 Methods, kits, agents and apparatuses for transduction

US Patent 12128069 Treatment of cancer using chimeric antigen receptor and protein kinase a blocker

US Patent 12065492 Anti-B7-H6 antibody, fusion proteins, and methods of using the same

US Patent 12065490 Chimeric antigen receptors and methods of making

US Patent 12024559 Fusions with CD8 antigen binding molecules for modulating immune cell function

US Patent 12018080 Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway

US Patent 12018077 Methods of treatments using antigen-binding proteins targeting CD56

US Patent 12015092 Physical forms of MXene materials exhibiting novel electrical and optical characteristics

US Patent 12006356 Anti-CCT5 binding molecules and chimeric antigen receptors comprising the same

US Patent 12005081 Chimeric receptors and methods of use thereof

US Patent 11999802 Compositions and methods for selective protein degradation

US Patent 11999794 Human mesothelin chimeric antigen receptors and uses thereof

US Patent 11994512 Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity

US Patent 11992503 Prostate-specific membrane antigen cars and methods of use thereof

US Patent 11981922 Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment

US Patent 11981731 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

US Patent 11975026 CD19 and CD22 chimeric antigen receptors and uses thereof

US Patent 11963966 Compositions and methods for treating ovarian tumors